Mendelian Randomization for Strengthening Causal Inference in Observational Studies

Identification of environmentally modifiable factors causally influencing disease risk is fundamental to public-health improvement strategies. Unfortunately, observational epidemiological studies are limited in their ability to reliably identify such causal associations, reflected in the many cases in which conventional epidemiological studies have apparently identified such associations that randomized controlled trials have failed to verify. The use of genetic variants as proxy measures of exposure —an application of the Mendelian randomization principle—can contribute to strengthening causal inference. Genetic variants are not subject to bias due to reverse causation (disease processes influencing exposure, rather than vice versa) or recall bias, and if simple precautions are applied, they are not influenced by confounding or attenuation by errors. The principles of Mendelian randomization are illustrated with specific reference to studies of the effects of alcohol intake on various health-related outcomes through the utilization of genetic variants related to alcohol metabolism (in ALDH2 and ADH1B). Ways of incorporating Gene × Environment interactions into the Mendelian randomization framework are developed, and the strengths and limitations of the approach discussed.

[1]  N. Risch,et al.  Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. , 2009, JAMA.

[2]  A. Shaper Alcohol, the heart, and health. , 1993, American journal of public health.

[3]  E. Rimm Commentary: alcohol and coronary heart disease--laying the foundation for future work. , 2001, International journal of epidemiology.

[4]  D. Rao,et al.  An epidemiologic approach to gene‐environment interaction , 1990, Genetic epidemiology.

[5]  P. Elliott,et al.  Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI , 2008, Diabetes.

[6]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[7]  P. Baird Genetic Technologies and Achieving Health for Populations , 2000, International journal of health services : planning, administration, evaluation.

[8]  Richard Gray,et al.  Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. , 2004, International journal of epidemiology.

[9]  M. Marmot Commentary: reflections on alcohol and coronary heart disease. , 2001, International journal of epidemiology.

[10]  David Clayton,et al.  Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.

[11]  S. Higuchi,et al.  Aldehyde dehydrogenase genotypes In Japanese alcoholics , 1994, The Lancet.

[12]  Charles Darwin,et al.  The Effects of Cross and Self Fertilisation in the Vegetable Kingdom , 1972 .

[13]  S. Lewis,et al.  Alcohol Intake and Blood Pressure: A Systematic Review Implementing a Mendelian Randomization Approach , 2008, PLoS medicine.

[14]  D. Kandel,et al.  From beer to crack: developmental patterns of drug involvement. , 1993, American journal of public health.

[15]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[16]  Sarah Parish,et al.  Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: Test of causality by "Mendelian randomisation" , 2000 .

[17]  Shah Ebrahim,et al.  Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?: Evidence from a Meta-Analysis of Genetic Association Studies , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[18]  C. Waddington Canalization of Development and the Inheritance of Acquired Characters , 1942, Nature.

[19]  H. Wolf,et al.  N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark , 1979, Environmental health perspectives.

[20]  S. Ebrahim,et al.  What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? , 2005, BMJ : British Medical Journal.

[21]  Tom R. Gaunt,et al.  C-reactive protein and its role in metabolic syndrome: mendelian randomisation study , 2005, The Lancet.

[22]  Ruth Ottman Gene-environment interaction: definitions and study designs. , 1996 .

[23]  Fibrinogen, social position, and "Mendelian randomisation". , 2004, Journal of epidemiology and community health.

[24]  S. Vichi,et al.  Metabolic and genetic factors contributing to alcohol induced effects and fetal alcohol syndrome , 2007, Neuroscience & Biobehavioral Reviews.

[25]  S. Lewis,et al.  Alcohol, ALDH2, and Esophageal Cancer: A Meta-analysis Which Illustrates the Potentials and Limitations of a Mendelian Randomization Approach , 2005, Cancer Epidemiology Biomarkers & Prevention.

[26]  Nicholas J Timpson,et al.  How Does Body Fat Influence Bone Mass in Childhood? A Mendelian Randomization Approach , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  B. Garvik,et al.  Principles for the Buffering of Genetic Variation , 2001, Science.

[28]  Fibrinogen, social position, and “Mendelian randomisation” , 2004 .

[29]  Ting-kai Li,et al.  Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in chinese patients , 1994, Hepatology.

[30]  W. Iacono,et al.  Mendelian randomization: A novel test of the gateway hypothesis and models of gene–environment interplay , 2007, Development and Psychopathology.

[31]  F. C. Heredity and Politics , 1938, Nature.

[32]  A. Berkowitz Our genes, ourselves? , 1996 .

[33]  N. Timpson,et al.  Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization , 2008, Annals of medicine.

[34]  D. Lawlor,et al.  Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology , 2007, PLoS medicine.

[35]  Lyla M. Hernandez,et al.  Genes, Behavior, and the Social Environment:: Moving Beyond the Nature/Nurture Debate , 2006 .

[36]  R. Glynn Commentary: genes as instruments for evaluation of markers and causes. , 2006, International journal of epidemiology.

[37]  S. Ebrahim,et al.  Mendelian randomization: prospects, potentials, and limitations. , 2004, International journal of epidemiology.

[38]  R. Krauss,et al.  The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. , 1984, The New England journal of medicine.

[39]  F. Memik Alcohol and esophageal cancer, is there an exaggerated accusation? , 2003, Hepato-gastroenterology.

[40]  Josef Parnas,et al.  A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. , 2002, American journal of human genetics.

[41]  W. Thompson,et al.  Effect modification and the limits of biological inference from epidemiologic data. , 1991, Journal of clinical epidemiology.

[42]  Richard C. Strohman,et al.  Ancient Genomes, Wise Bodies, Unhealthy People: Limits of a Genetic Paradigm in Biology and Medicine , 2015, Perspectives in biology and medicine.

[43]  Ting-kai Li,et al.  Alcohol and ADH2 in Israel: Ashkenazis, Sephardics, and recent Russian immigrants. , 2002, The American journal of psychiatry.

[44]  Giovanni Montana,et al.  Statistical methods in genetics , 2006, Briefings Bioinform..

[45]  T. Morgan The Relation of Genetics to Physiology and Medicine , 1935 .

[46]  Paul C. D. Johnson,et al.  Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. , 2010, The American journal of clinical nutrition.

[47]  Folate supplementation and cardiovascular disease. , 2006 .

[48]  E. Rimm,et al.  Alcohol Consumption and Risk for Coronary Heart Disease among Men with Hypertension , 2007, Annals of Internal Medicine.

[49]  N. Malats,et al.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses , 2005, The Lancet.

[50]  A. Wilkins,et al.  Canalization: a molecular genetic perspective. , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[51]  F. Paccaud,et al.  Commentary: alcohol, coronary heart disease and public health: which evidence-based policy. , 2001, International journal of epidemiology.

[52]  P. Schnohr,et al.  Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. , 1998, The New England journal of medicine.

[53]  G. Davey Smith,et al.  Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 years of follow up , 1999, BMJ.

[54]  George Davey Smith,et al.  Capitalizing on Mendelian randomization to assess the effects of treatments. , 2007, Journal of the Royal Society of Medicine.

[55]  M. Uusitupa,et al.  Does lactose intolerance predispose to low bone density? A population-based study of perimenopausal Finnish women. , 1996, Bone.

[56]  Joseph D Terwilliger,et al.  Confounding, ascertainment bias, and the blind quest for a genetic ‘fountain of youth’ , 2003, Annals of medicine.

[57]  B. Butland,et al.  Alcohol and high-density-lipoprotein cholesterol:a randomized controlled trial , 1986, British Journal of Nutrition.

[58]  P. Brennan,et al.  Multiple ADH genes are associated with upper aerodigestive cancers , 2008, Nature Genetics.

[59]  A. Caspi,et al.  Role of Genotype in the Cycle of Violence in Maltreated Children , 2002, Science.

[60]  U. Wolf The genetic contribution to the phenotype , 1995, Human Genetics.

[61]  Sarah Lewis,et al.  Genetic epidemiology and public health: hope, hype, and future prospects , 2005, The Lancet.

[62]  Lyle J Palmer,et al.  Genetic Epidemiology 4 Shaking the tree : mapping complex disease genes with linkage disequilibrium , 2022 .

[63]  N Enomoto,et al.  Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. , 1991, Alcoholism, clinical and experimental research.

[64]  Jonathan Michael Kaplan,et al.  Genes `for’ Phenotypes: A Modern History View , 2001 .

[65]  G. D. Whedon,et al.  Osteoporosis, intestinal lactase deficiency and low dietary calcium intake. , 1967, The New England journal of medicine.

[66]  Noam Shomron,et al.  Canalization of development by microRNAs , 2006, Nature Genetics.

[67]  V. Debat,et al.  Mapping phenotypes: canalization, plasticity and developmental stability , 2001 .

[68]  D. Kandel,et al.  Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. , 1992, Journal of studies on alcohol.

[69]  G. Robinson,et al.  Alcohol and high-density lipoproteins. , 1980, Canadian Medical Association journal.

[70]  Tom R. Gaunt,et al.  The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants , 2008, PloS one.

[71]  W. Gelbart,et al.  Databases in genomic research. , 1998, Science.

[72]  M. D. De Buyzere,et al.  Effect of haptoglobin on the metabolism of vitamin C. , 1997, The American journal of clinical nutrition.

[73]  F. Stickel,et al.  “Allgemeine und systematische Pharmakologie und Toxikologie” WS 18/19 Seminarthema: Chemische Kanzerogenese , 2017 .

[74]  S. Rutherford,et al.  From genotype to phenotype: buffering mechanisms and the storage of genetic information , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[75]  David V Conti,et al.  Commentary: the concept of 'Mendelian Randomization'. , 2004, International journal of epidemiology.

[76]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[77]  S. Chanock,et al.  Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23A2). , 2001, The Journal of nutrition.

[78]  S. Ebrahim,et al.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? , 2008, Human Genetics.

[79]  Bernard Keavney,et al.  Genetic epidemiological studies of coronary heart disease. , 2002, International journal of epidemiology.

[80]  W. T. THISELTON DYER,et al.  The Effects of Cross- and Self-Fertilisation in the Vegetable Kingdom , 1877, Nature.

[81]  D. McGill,et al.  Lactase deficiency: prevalence in osteoporosis. , 1978, Annals of internal medicine.

[82]  A. Phillips,et al.  Inflation in epidemiology: “The proof and measurement of association between two things” revisited , 1996, BMJ.

[83]  James Tabery Causation in the nature -nurture debate: The case of genotype -environment interaction , 2007 .

[84]  N. Holtzman Putting the Search for Genes in Perspective , 2001, International journal of health services : planning, administration, evaluation.

[85]  G. Smith Randomised by (your) god: robust inference from an observational study design , 2006, Journal of Epidemiology and Community Health.

[86]  A. Klatsky,et al.  Commentary: could abstinence from alcohol be hazardous to your health? , 2001, International journal of epidemiology.

[87]  Garth A. Gibson,et al.  Canalization in evolutionary genetics: a stabilizing theory? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[88]  L. Burd Interventions in FASD: we must do better , 2007 .

[89]  Ting-kai Li,et al.  Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[90]  Ting-kai Li,et al.  Protective effects of the alcohol dehydrogenase-ADH1B allele in children exposed to alcohol during pregnancy. , 2006, The Journal of pediatrics.

[91]  Shoji Suzuki,et al.  Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[92]  James Tabery Biometric and developmental gene–environment interactions: Looking back, moving forward , 2007, Development and Psychopathology.

[93]  K. Mossman The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[94]  A. Caspi,et al.  Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism , 2007, Proceedings of the National Academy of Sciences.

[95]  K. Weiss,et al.  How many diseases does it take to map a gene with SNPs? , 2000, Nature Genetics.

[96]  T. Kitami,et al.  Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication , 2002, Nature Genetics.

[97]  C. V. van Duijn,et al.  Aldehyde Dehydrogenase 2 and Head and Neck Cancer: A Meta-analysis Implementing a Mendelian Randomization Approach , 2009, Cancer Epidemiology Biomarkers & Prevention.